Clinical Research Site

Las Vegas, Nevada 89128

3 studies enrolling now · 14 studies all time

What they study most

ADHD, Agitation in Patients With Dementia of the Alzheimer's Type, Agitation,Psychomotor, Alzheimer Disease, Cataplexy, Depression, Essential Hypertension, Excessive Daytime Sleepiness, Fibromyalgia, Hypogonadism, Major Depressive Disorder, Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Studies at this site

• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
• A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS) — Completed
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) — Completed
• Assessing Clinical Outcomes in Alzheimer's Disease Agitation — Completed
• Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed
• An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension — Completed
• A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism — Completed